nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CYP2B6—Artemether—malaria	0.0708	0.101	CbGbCtD
Loperamide—CYP2C8—Sulfadiazine—malaria	0.0631	0.0896	CbGbCtD
Loperamide—CYP2C8—Pyrimethamine—malaria	0.0631	0.0896	CbGbCtD
Loperamide—CYP3A4—Clindamycin—malaria	0.0445	0.0632	CbGbCtD
Loperamide—CYP2D6—Pyrimethamine—malaria	0.0402	0.0571	CbGbCtD
Loperamide—CYP2B6—Quinidine—malaria	0.0377	0.0535	CbGbCtD
Loperamide—CYP2D6—Artemether—malaria	0.0342	0.0486	CbGbCtD
Loperamide—CYP2C8—Quinine—malaria	0.0325	0.0461	CbGbCtD
Loperamide—CYP2D6—Proguanil—malaria	0.0322	0.0457	CbGbCtD
Loperamide—CYP2D6—Quinidine barbiturate—malaria	0.0305	0.0433	CbGbCtD
Loperamide—CYP2C8—Quinidine—malaria	0.0286	0.0406	CbGbCtD
Loperamide—CYP3A4—Sulfadiazine—malaria	0.0256	0.0363	CbGbCtD
Loperamide—CYP2C8—Dapsone—malaria	0.0246	0.035	CbGbCtD
Loperamide—ABCB1—Quinine—malaria	0.022	0.0312	CbGbCtD
Loperamide—CYP3A4—Artemether—malaria	0.0217	0.0309	CbGbCtD
Loperamide—CYP2D6—Quinine—malaria	0.0207	0.0294	CbGbCtD
Loperamide—CYP3A4—Proguanil—malaria	0.0204	0.029	CbGbCtD
Loperamide—CYP3A4—Doxycycline—malaria	0.0194	0.0275	CbGbCtD
Loperamide—ABCB1—Quinidine—malaria	0.0193	0.0274	CbGbCtD
Loperamide—CYP2D6—Quinidine—malaria	0.0182	0.0259	CbGbCtD
Loperamide—CYP3A4—Quinine—malaria	0.0132	0.0187	CbGbCtD
Loperamide—CYP3A4—Quinidine—malaria	0.0116	0.0164	CbGbCtD
Loperamide—CYP3A4—Dapsone—malaria	0.00999	0.0142	CbGbCtD
Loperamide—POMC—blood plasma—malaria	0.00815	0.0941	CbGeAlD
Loperamide—POMC—hematopoietic system—malaria	0.00451	0.0521	CbGeAlD
Loperamide—Abdominal bloating—Clindamycin—malaria	0.0039	0.0253	CcSEcCtD
Loperamide—Epigastric pain—Quinine—malaria	0.00377	0.0245	CcSEcCtD
Loperamide—Epigastric pain—Quinidine—malaria	0.00377	0.0245	CcSEcCtD
Loperamide—POMC—kidney—malaria	0.0037	0.0427	CbGeAlD
Loperamide—Abdominal bloating—Pentoxifylline—malaria	0.00345	0.0224	CcSEcCtD
Loperamide—Epigastric pain—Quinidine barbiturate—malaria	0.0034	0.0221	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Pyrimethamine—malaria	0.00315	0.0205	CcSEcCtD
Loperamide—POMC—digestive system—malaria	0.00314	0.0362	CbGeAlD
Loperamide—POMC—blood—malaria	0.00299	0.0345	CbGeAlD
Loperamide—Abdominal cramps—Clindamycin—malaria	0.00275	0.0179	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Pyrimethamine—malaria	0.00267	0.0174	CcSEcCtD
Loperamide—CALM2—endothelium—malaria	0.00251	0.0289	CbGeAlD
Loperamide—CALM1—endothelium—malaria	0.0025	0.0288	CbGeAlD
Loperamide—POMC—liver—malaria	0.00234	0.027	CbGeAlD
Loperamide—Erythema multiforme—Pyrimethamine—malaria	0.00229	0.0149	CcSEcCtD
Loperamide—CALM2—blood plasma—malaria	0.00223	0.0257	CbGeAlD
Loperamide—CALM1—blood plasma—malaria	0.00222	0.0256	CbGeAlD
Loperamide—OPRD1—kidney—malaria	0.00204	0.0235	CbGeAlD
Loperamide—Anaphylactoid reaction—Sulfadiazine—malaria	0.00187	0.0121	CcSEcCtD
Loperamide—POMC—brain—malaria	0.00185	0.0214	CbGeAlD
Loperamide—CYP2C8—blood plasma—malaria	0.00185	0.0213	CbGeAlD
Loperamide—CACNA1A—brain—malaria	0.00177	0.0204	CbGeAlD
Loperamide—Anaphylactic shock—Pyrimethamine—malaria	0.00172	0.0112	CcSEcCtD
Loperamide—Immune system disorder—Proguanil—malaria	0.0017	0.0111	CcSEcCtD
Loperamide—OPRM1—hematopoietic system—malaria	0.0017	0.0196	CbGeAlD
Loperamide—CYP2B6—blood plasma—malaria	0.00166	0.0191	CbGeAlD
Loperamide—CALM3—saliva-secreting gland—malaria	0.00164	0.019	CbGeAlD
Loperamide—Toxic epidermal necrolysis—Sulfadiazine—malaria	0.00163	0.0106	CcSEcCtD
Loperamide—Depressed level of consciousness—Quinidine barbiturate—malaria	0.00159	0.0103	CcSEcCtD
Loperamide—Dermatitis bullous—Clindamycin—malaria	0.00141	0.00915	CcSEcCtD
Loperamide—Anaphylactoid reaction—Clindamycin—malaria	0.00139	0.00904	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00139	0.00901	CcSEcCtD
Loperamide—Dermatitis bullous—Quinidine—malaria	0.00138	0.00898	CcSEcCtD
Loperamide—Dermatitis bullous—Quinine—malaria	0.00138	0.00898	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.00138	0.00898	CcSEcCtD
Loperamide—Nervous system disorder—Proguanil—malaria	0.00131	0.00853	CcSEcCtD
Loperamide—Skin disorder—Proguanil—malaria	0.0013	0.00845	CcSEcCtD
Loperamide—CALM2—saliva-secreting gland—malaria	0.00129	0.0149	CbGeAlD
Loperamide—CALM1—saliva-secreting gland—malaria	0.00128	0.0148	CbGeAlD
Loperamide—Hypersensitivity—Pyrimethamine—malaria	0.00127	0.00823	CcSEcCtD
Loperamide—CYP3A4—blood plasma—malaria	0.00125	0.0144	CbGeAlD
Loperamide—Dermatitis bullous—Quinidine barbiturate—malaria	0.00125	0.0081	CcSEcCtD
Loperamide—CALM2—hematopoietic system—malaria	0.00123	0.0142	CbGeAlD
Loperamide—Abdominal pain upper—Clindamycin—malaria	0.00123	0.00799	CcSEcCtD
Loperamide—Anaphylactoid reaction—Pentoxifylline—malaria	0.00123	0.00799	CcSEcCtD
Loperamide—CYP2D6—blood plasma—malaria	0.00123	0.0142	CbGeAlD
Loperamide—CALM1—hematopoietic system—malaria	0.00123	0.0142	CbGeAlD
Loperamide—Toxic epidermal necrolysis—Clindamycin—malaria	0.00121	0.00788	CcSEcCtD
Loperamide—Abdominal pain upper—Quinidine—malaria	0.00121	0.00784	CcSEcCtD
Loperamide—Abdominal pain upper—Quinine—malaria	0.00121	0.00784	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Quinine—malaria	0.00119	0.00773	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Quinidine—malaria	0.00119	0.00773	CcSEcCtD
Loperamide—Erythema multiforme—Sulfadiazine—malaria	0.00118	0.00768	CcSEcCtD
Loperamide—Abdominal distension—Clindamycin—malaria	0.00117	0.00761	CcSEcCtD
Loperamide—Gastrointestinal disorder—Proguanil—malaria	0.00116	0.00751	CcSEcCtD
Loperamide—OPRM1—blood—malaria	0.00112	0.013	CbGeAlD
Loperamide—Gastrointestinal pain—Proguanil—malaria	0.0011	0.00711	CcSEcCtD
Loperamide—Vomiting—Pyrimethamine—malaria	0.00109	0.0071	CcSEcCtD
Loperamide—Abdominal pain upper—Quinidine barbiturate—malaria	0.00109	0.00707	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.00107	0.00697	CcSEcCtD
Loperamide—Abdominal pain—Proguanil—malaria	0.00106	0.00688	CcSEcCtD
Loperamide—CALM3—blood—malaria	0.00104	0.012	CbGeAlD
Loperamide—Abdominal distension—Pentoxifylline—malaria	0.00104	0.00673	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Clindamycin—malaria	0.00103	0.00668	CcSEcCtD
Loperamide—OPRD1—brain—malaria	0.00102	0.0118	CbGeAlD
Loperamide—CYP2C8—hematopoietic system—malaria	0.00102	0.0118	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Quinidine—malaria	0.00101	0.00656	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Quinine—malaria	0.00101	0.00656	CcSEcCtD
Loperamide—CALM2—kidney—malaria	0.00101	0.0117	CbGeAlD
Loperamide—CALM3—bone marrow—malaria	0.00101	0.0116	CbGeAlD
Loperamide—CALM1—kidney—malaria	0.001	0.0116	CbGeAlD
Loperamide—OPRK1—brain—malaria	0.000981	0.0113	CbGeAlD
Loperamide—Drowsiness—Quinidine barbiturate—malaria	0.000919	0.00597	CcSEcCtD
Loperamide—Drowsiness—Pentoxifylline—malaria	0.000918	0.00596	CcSEcCtD
Loperamide—Diarrhoea—Proguanil—malaria	0.000917	0.00595	CcSEcCtD
Loperamide—CYP2B6—hematopoietic system—malaria	0.000915	0.0106	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000912	0.00592	CcSEcCtD
Loperamide—Urinary tract disorder—Quinine—malaria	0.000903	0.00586	CcSEcCtD
Loperamide—Urinary tract disorder—Quinidine—malaria	0.000903	0.00586	CcSEcCtD
Loperamide—Urethral disorder—Quinine—malaria	0.000897	0.00582	CcSEcCtD
Loperamide—Urethral disorder—Quinidine—malaria	0.000897	0.00582	CcSEcCtD
Loperamide—Anaphylactic shock—Sulfadiazine—malaria	0.000889	0.00577	CcSEcCtD
Loperamide—ABCB1—blood plasma—malaria	0.000885	0.0102	CbGeAlD
Loperamide—Erythema multiforme—Clindamycin—malaria	0.000881	0.00572	CcSEcCtD
Loperamide—Erythema multiforme—Quinine—malaria	0.000865	0.00561	CcSEcCtD
Loperamide—Erythema multiforme—Quinidine—malaria	0.000865	0.00561	CcSEcCtD
Loperamide—CALM2—digestive system—malaria	0.000856	0.00989	CbGeAlD
Loperamide—CALM1—digestive system—malaria	0.000852	0.00984	CbGeAlD
Loperamide—Vomiting—Proguanil—malaria	0.000852	0.00553	CcSEcCtD
Loperamide—Rash—Proguanil—malaria	0.000845	0.00548	CcSEcCtD
Loperamide—Dermatitis—Proguanil—malaria	0.000844	0.00548	CcSEcCtD
Loperamide—Headache—Proguanil—malaria	0.000839	0.00545	CcSEcCtD
Loperamide—CYP2C8—kidney—malaria	0.000837	0.00966	CbGeAlD
Loperamide—Immune system disorder—Quinidine—malaria	0.000826	0.00536	CcSEcCtD
Loperamide—Immune system disorder—Quinine—malaria	0.000826	0.00536	CcSEcCtD
Loperamide—CALM2—blood—malaria	0.000816	0.00942	CbGeAlD
Loperamide—Urinary tract disorder—Quinidine barbiturate—malaria	0.000815	0.00529	CcSEcCtD
Loperamide—CALM3—liver—malaria	0.000812	0.00938	CbGeAlD
Loperamide—CALM1—blood—malaria	0.000812	0.00938	CbGeAlD
Loperamide—Urethral disorder—Quinidine barbiturate—malaria	0.000809	0.00525	CcSEcCtD
Loperamide—Flatulence—Clindamycin—malaria	0.0008	0.00519	CcSEcCtD
Loperamide—Nausea—Proguanil—malaria	0.000796	0.00517	CcSEcCtD
Loperamide—CALM2—bone marrow—malaria	0.000789	0.00911	CbGeAlD
Loperamide—CALM1—bone marrow—malaria	0.000786	0.00907	CbGeAlD
Loperamide—Erythema multiforme—Quinidine barbiturate—malaria	0.00078	0.00507	CcSEcCtD
Loperamide—Gastrointestinal disorder—Sulfadiazine—malaria	0.000768	0.00498	CcSEcCtD
Loperamide—CYP2B6—kidney—malaria	0.00075	0.00866	CbGeAlD
Loperamide—Immune system disorder—Quinidine barbiturate—malaria	0.000746	0.00484	CcSEcCtD
Loperamide—Immune system disorder—Pentoxifylline—malaria	0.000744	0.00483	CcSEcCtD
Loperamide—Angioedema—Quinidine—malaria	0.000727	0.00472	CcSEcCtD
Loperamide—Angioedema—Quinine—malaria	0.000727	0.00472	CcSEcCtD
Loperamide—Gastrointestinal pain—Sulfadiazine—malaria	0.000727	0.00472	CcSEcCtD
Loperamide—Flatulence—Pentoxifylline—malaria	0.000707	0.00459	CcSEcCtD
Loperamide—Urticaria—Sulfadiazine—malaria	0.000707	0.00459	CcSEcCtD
Loperamide—Abdominal pain—Sulfadiazine—malaria	0.000703	0.00456	CcSEcCtD
Loperamide—Loss of consciousness—Quinine—malaria	0.0007	0.00454	CcSEcCtD
Loperamide—Loss of consciousness—Quinidine—malaria	0.0007	0.00454	CcSEcCtD
Loperamide—OPRM1—brain—malaria	0.000698	0.00805	CbGeAlD
Loperamide—CYP3A4—hematopoietic system—malaria	0.000691	0.00798	CbGeAlD
Loperamide—Discomfort—Clindamycin—malaria	0.000683	0.00443	CcSEcCtD
Loperamide—CYP2D6—hematopoietic system—malaria	0.00068	0.00785	CbGeAlD
Loperamide—CYP2C8—blood—malaria	0.000676	0.00781	CbGeAlD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000673	0.00437	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000673	0.00437	CcSEcCtD
Loperamide—Anaphylactic shock—Clindamycin—malaria	0.000662	0.0043	CcSEcCtD
Loperamide—Angioedema—Quinidine barbiturate—malaria	0.000657	0.00426	CcSEcCtD
Loperamide—Angioedema—Pentoxifylline—malaria	0.000655	0.00425	CcSEcCtD
Loperamide—Hypersensitivity—Sulfadiazine—malaria	0.000655	0.00425	CcSEcCtD
Loperamide—CALM3—brain—malaria	0.000645	0.00744	CbGeAlD
Loperamide—CALM2—liver—malaria	0.000638	0.00737	CbGeAlD
Loperamide—Nervous system disorder—Quinidine—malaria	0.000637	0.00414	CcSEcCtD
Loperamide—Nervous system disorder—Quinine—malaria	0.000637	0.00414	CcSEcCtD
Loperamide—CYP2B6—digestive system—malaria	0.000637	0.00735	CbGeAlD
Loperamide—CALM1—liver—malaria	0.000635	0.00733	CbGeAlD
Loperamide—Loss of consciousness—Quinidine barbiturate—malaria	0.000632	0.0041	CcSEcCtD
Loperamide—Skin disorder—Quinidine—malaria	0.000631	0.0041	CcSEcCtD
Loperamide—Skin disorder—Quinine—malaria	0.000631	0.0041	CcSEcCtD
Loperamide—Pruritus—Sulfadiazine—malaria	0.000629	0.00409	CcSEcCtD
Loperamide—Diarrhoea—Sulfadiazine—malaria	0.000609	0.00395	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000608	0.00394	CcSEcCtD
Loperamide—CYP2B6—blood—malaria	0.000607	0.007	CbGeAlD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000606	0.00394	CcSEcCtD
Loperamide—Discomfort—Pentoxifylline—malaria	0.000603	0.00392	CcSEcCtD
Loperamide—Dry mouth—Pentoxifylline—malaria	0.000597	0.00388	CcSEcCtD
Loperamide—Anaphylactic shock—Pentoxifylline—malaria	0.000585	0.0038	CcSEcCtD
Loperamide—Dyspepsia—Clindamycin—malaria	0.000583	0.00378	CcSEcCtD
Loperamide—Nervous system disorder—Quinidine barbiturate—malaria	0.000575	0.00373	CcSEcCtD
Loperamide—Gastrointestinal disorder—Clindamycin—malaria	0.000572	0.00371	CcSEcCtD
Loperamide—Fatigue—Clindamycin—malaria	0.000571	0.00371	CcSEcCtD
Loperamide—Skin disorder—Quinidine barbiturate—malaria	0.00057	0.0037	CcSEcCtD
Loperamide—Skin disorder—Pentoxifylline—malaria	0.000569	0.00369	CcSEcCtD
Loperamide—CYP3A4—kidney—malaria	0.000567	0.00654	CbGeAlD
Loperamide—Constipation—Clindamycin—malaria	0.000566	0.00368	CcSEcCtD
Loperamide—Vomiting—Sulfadiazine—malaria	0.000566	0.00367	CcSEcCtD
Loperamide—Gastrointestinal disorder—Quinidine—malaria	0.000561	0.00364	CcSEcCtD
Loperamide—Gastrointestinal disorder—Quinine—malaria	0.000561	0.00364	CcSEcCtD
Loperamide—Rash—Sulfadiazine—malaria	0.000561	0.00364	CcSEcCtD
Loperamide—Dermatitis—Sulfadiazine—malaria	0.00056	0.00364	CcSEcCtD
Loperamide—Gastrointestinal pain—Dapsone—malaria	0.00056	0.00363	CcSEcCtD
Loperamide—CYP2D6—kidney—malaria	0.000558	0.00644	CbGeAlD
Loperamide—Headache—Sulfadiazine—malaria	0.000557	0.00362	CcSEcCtD
Loperamide—Gastrointestinal pain—Clindamycin—malaria	0.000542	0.00352	CcSEcCtD
Loperamide—Abdominal pain—Dapsone—malaria	0.000541	0.00351	CcSEcCtD
Loperamide—Gastrointestinal pain—Quinidine—malaria	0.000531	0.00345	CcSEcCtD
Loperamide—Gastrointestinal pain—Quinine—malaria	0.000531	0.00345	CcSEcCtD
Loperamide—CYP2C8—liver—malaria	0.000529	0.0061	CbGeAlD
Loperamide—Nausea—Sulfadiazine—malaria	0.000528	0.00343	CcSEcCtD
Loperamide—Urticaria—Clindamycin—malaria	0.000526	0.00342	CcSEcCtD
Loperamide—Abdominal pain—Clindamycin—malaria	0.000524	0.0034	CcSEcCtD
Loperamide—Somnolence—Quinidine barbiturate—malaria	0.000521	0.00338	CcSEcCtD
Loperamide—Somnolence—Pentoxifylline—malaria	0.00052	0.00338	CcSEcCtD
Loperamide—Urticaria—Quinine—malaria	0.000516	0.00335	CcSEcCtD
Loperamide—Urticaria—Quinidine—malaria	0.000516	0.00335	CcSEcCtD
Loperamide—Dyspepsia—Pentoxifylline—malaria	0.000515	0.00334	CcSEcCtD
Loperamide—Abdominal pain—Quinidine—malaria	0.000514	0.00333	CcSEcCtD
Loperamide—Abdominal pain—Quinine—malaria	0.000514	0.00333	CcSEcCtD
Loperamide—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000506	0.00329	CcSEcCtD
Loperamide—CALM2—brain—malaria	0.000506	0.00584	CbGeAlD
Loperamide—CALM1—brain—malaria	0.000504	0.00582	CbGeAlD
Loperamide—Constipation—Quinidine barbiturate—malaria	0.000501	0.00326	CcSEcCtD
Loperamide—Constipation—Pentoxifylline—malaria	0.000501	0.00325	CcSEcCtD
Loperamide—ABCB1—hematopoietic system—malaria	0.000489	0.00565	CbGeAlD
Loperamide—Hypersensitivity—Clindamycin—malaria	0.000488	0.00317	CcSEcCtD
Loperamide—CYP3A4—digestive system—malaria	0.000481	0.00555	CbGeAlD
Loperamide—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00048	0.00311	CcSEcCtD
Loperamide—Hypersensitivity—Quinidine—malaria	0.000479	0.00311	CcSEcCtD
Loperamide—Hypersensitivity—Quinine—malaria	0.000479	0.00311	CcSEcCtD
Loperamide—Gastrointestinal pain—Pentoxifylline—malaria	0.000479	0.00311	CcSEcCtD
Loperamide—Asthenia—Clindamycin—malaria	0.000475	0.00308	CcSEcCtD
Loperamide—CYP2B6—liver—malaria	0.000474	0.00548	CbGeAlD
Loperamide—CYP2D6—digestive system—malaria	0.000473	0.00546	CbGeAlD
Loperamide—Pruritus—Clindamycin—malaria	0.000469	0.00304	CcSEcCtD
Loperamide—Asthenia—Quinidine—malaria	0.000466	0.00303	CcSEcCtD
Loperamide—Asthenia—Quinine—malaria	0.000466	0.00303	CcSEcCtD
Loperamide—Urticaria—Quinidine barbiturate—malaria	0.000466	0.00302	CcSEcCtD
Loperamide—Urticaria—Pentoxifylline—malaria	0.000465	0.00302	CcSEcCtD
Loperamide—Abdominal pain—Quinidine barbiturate—malaria	0.000464	0.00301	CcSEcCtD
Loperamide—Abdominal pain—Pentoxifylline—malaria	0.000463	0.003	CcSEcCtD
Loperamide—Pruritus—Quinine—malaria	0.00046	0.00298	CcSEcCtD
Loperamide—Pruritus—Quinidine—malaria	0.00046	0.00298	CcSEcCtD
Loperamide—CYP3A4—blood—malaria	0.000458	0.00529	CbGeAlD
Loperamide—Diarrhoea—Clindamycin—malaria	0.000453	0.00294	CcSEcCtD
Loperamide—CYP2D6—blood—malaria	0.000451	0.0052	CbGeAlD
Loperamide—Diarrhoea—Quinidine—malaria	0.000445	0.00289	CcSEcCtD
Loperamide—Diarrhoea—Quinine—malaria	0.000445	0.00289	CcSEcCtD
Loperamide—Dizziness—Clindamycin—malaria	0.000438	0.00284	CcSEcCtD
Loperamide—Vomiting—Dapsone—malaria	0.000435	0.00283	CcSEcCtD
Loperamide—Hypersensitivity—Quinidine barbiturate—malaria	0.000432	0.0028	CcSEcCtD
Loperamide—Hypersensitivity—Pentoxifylline—malaria	0.000431	0.0028	CcSEcCtD
Loperamide—Dizziness—Quinine—malaria	0.00043	0.00279	CcSEcCtD
Loperamide—Dizziness—Quinidine—malaria	0.00043	0.00279	CcSEcCtD
Loperamide—Headache—Dapsone—malaria	0.000429	0.00278	CcSEcCtD
Loperamide—Vomiting—Clindamycin—malaria	0.000421	0.00273	CcSEcCtD
Loperamide—Asthenia—Quinidine barbiturate—malaria	0.000421	0.00273	CcSEcCtD
Loperamide—Asthenia—Pentoxifylline—malaria	0.00042	0.00273	CcSEcCtD
Loperamide—CYP2C8—brain—malaria	0.00042	0.00484	CbGeAlD
Loperamide—Rash—Clindamycin—malaria	0.000418	0.00271	CcSEcCtD
Loperamide—Dermatitis—Clindamycin—malaria	0.000417	0.00271	CcSEcCtD
Loperamide—Headache—Clindamycin—malaria	0.000415	0.00269	CcSEcCtD
Loperamide—Pruritus—Quinidine barbiturate—malaria	0.000415	0.00269	CcSEcCtD
Loperamide—Pruritus—Pentoxifylline—malaria	0.000414	0.00269	CcSEcCtD
Loperamide—Vomiting—Quinidine—malaria	0.000413	0.00268	CcSEcCtD
Loperamide—Vomiting—Quinine—malaria	0.000413	0.00268	CcSEcCtD
Loperamide—Rash—Quinidine—malaria	0.00041	0.00266	CcSEcCtD
Loperamide—Rash—Quinine—malaria	0.00041	0.00266	CcSEcCtD
Loperamide—Dermatitis—Quinidine—malaria	0.000409	0.00266	CcSEcCtD
Loperamide—Dermatitis—Quinine—malaria	0.000409	0.00266	CcSEcCtD
Loperamide—Headache—Quinine—malaria	0.000407	0.00264	CcSEcCtD
Loperamide—Headache—Quinidine—malaria	0.000407	0.00264	CcSEcCtD
Loperamide—Nausea—Dapsone—malaria	0.000407	0.00264	CcSEcCtD
Loperamide—Diarrhoea—Quinidine barbiturate—malaria	0.000401	0.0026	CcSEcCtD
Loperamide—ABCB1—kidney—malaria	0.000401	0.00463	CbGeAlD
Loperamide—Diarrhoea—Pentoxifylline—malaria	0.000401	0.0026	CcSEcCtD
Loperamide—Nausea—Clindamycin—malaria	0.000393	0.00255	CcSEcCtD
Loperamide—Dizziness—Quinidine barbiturate—malaria	0.000388	0.00252	CcSEcCtD
Loperamide—Dizziness—Pentoxifylline—malaria	0.000387	0.00251	CcSEcCtD
Loperamide—Nausea—Quinine—malaria	0.000386	0.00251	CcSEcCtD
Loperamide—Nausea—Quinidine—malaria	0.000386	0.00251	CcSEcCtD
Loperamide—CYP2B6—brain—malaria	0.000376	0.00434	CbGeAlD
Loperamide—Vomiting—Quinidine barbiturate—malaria	0.000373	0.00242	CcSEcCtD
Loperamide—Vomiting—Pentoxifylline—malaria	0.000372	0.00242	CcSEcCtD
Loperamide—Rash—Quinidine barbiturate—malaria	0.00037	0.0024	CcSEcCtD
Loperamide—Dermatitis—Quinidine barbiturate—malaria	0.000369	0.0024	CcSEcCtD
Loperamide—Rash—Pentoxifylline—malaria	0.000369	0.0024	CcSEcCtD
Loperamide—Dermatitis—Pentoxifylline—malaria	0.000369	0.00239	CcSEcCtD
Loperamide—Headache—Quinidine barbiturate—malaria	0.000367	0.00238	CcSEcCtD
Loperamide—Headache—Pentoxifylline—malaria	0.000367	0.00238	CcSEcCtD
Loperamide—CYP3A4—liver—malaria	0.000358	0.00413	CbGeAlD
Loperamide—CYP2D6—liver—malaria	0.000352	0.00407	CbGeAlD
Loperamide—Nausea—Quinidine barbiturate—malaria	0.000348	0.00226	CcSEcCtD
Loperamide—Nausea—Pentoxifylline—malaria	0.000348	0.00226	CcSEcCtD
Loperamide—ABCB1—digestive system—malaria	0.00034	0.00393	CbGeAlD
Loperamide—ABCB1—blood—malaria	0.000324	0.00374	CbGeAlD
Loperamide—ABCB1—bone marrow—malaria	0.000314	0.00362	CbGeAlD
Loperamide—CYP2D6—brain—malaria	0.00028	0.00323	CbGeAlD
Loperamide—ABCB1—liver—malaria	0.000254	0.00293	CbGeAlD
Loperamide—ABCB1—brain—malaria	0.000201	0.00232	CbGeAlD
Loperamide—CALM2—Disease—G6PD—malaria	3.29e-05	0.000596	CbGpPWpGaD
Loperamide—CALM1—Disease—G6PD—malaria	3.29e-05	0.000596	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PKLR—malaria	3.28e-05	0.000595	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—IL2—malaria	3.25e-05	0.000588	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—IL2—malaria	3.25e-05	0.000588	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—IL2—malaria	3.22e-05	0.000584	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—IL6—malaria	3.22e-05	0.000583	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—IL6—malaria	3.22e-05	0.000583	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—IL6—malaria	3.21e-05	0.000581	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PKLR—malaria	3.2e-05	0.000579	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SLC4A1—malaria	3.2e-05	0.000579	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—HBB—malaria	3.12e-05	0.000565	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PKLR—malaria	3.09e-05	0.00056	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PKLR—malaria	3.09e-05	0.00056	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—CD36—malaria	3.09e-05	0.00056	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SLC4A1—malaria	3.01e-05	0.000546	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—DECR1—malaria	3.01e-05	0.000545	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—CD36—malaria	2.99e-05	0.000541	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—CD36—malaria	2.99e-05	0.000541	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—G6PD—malaria	2.93e-05	0.00053	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD40LG—malaria	2.86e-05	0.000519	CbGpPWpGaD
Loperamide—CALM3—Metabolism—G6PD—malaria	2.85e-05	0.000516	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—HLA-B—malaria	2.83e-05	0.000514	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—DECR1—malaria	2.83e-05	0.000513	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD8A—malaria	2.83e-05	0.000513	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ACKR1—malaria	2.82e-05	0.000511	CbGpPWpGaD
Loperamide—CALM3—Immune System—FCGR2A—malaria	2.81e-05	0.000509	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PKLR—malaria	2.78e-05	0.000504	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CD36—malaria	2.78e-05	0.000504	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD40LG—malaria	2.77e-05	0.000502	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD40LG—malaria	2.77e-05	0.000502	CbGpPWpGaD
Loperamide—CALM2—Metabolism—G6PD—malaria	2.76e-05	0.000499	CbGpPWpGaD
Loperamide—CALM1—Metabolism—G6PD—malaria	2.76e-05	0.000499	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—HLA-B—malaria	2.74e-05	0.000497	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—HLA-B—malaria	2.74e-05	0.000497	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD8A—malaria	2.74e-05	0.000496	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD8A—malaria	2.74e-05	0.000496	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ACKR1—malaria	2.73e-05	0.000494	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ACKR1—malaria	2.73e-05	0.000494	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HLA-B—malaria	2.72e-05	0.000493	CbGpPWpGaD
Loperamide—CALM1—Immune System—FCGR2A—malaria	2.72e-05	0.000493	CbGpPWpGaD
Loperamide—CALM2—Immune System—FCGR2A—malaria	2.72e-05	0.000493	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—HBB—malaria	2.72e-05	0.000493	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling of activated FGFR—IL6—malaria	2.7e-05	0.00049	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CD36—malaria	2.69e-05	0.000487	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CD36—malaria	2.69e-05	0.000487	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD36—malaria	2.67e-05	0.000484	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HLA-B—malaria	2.63e-05	0.000477	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HLA-B—malaria	2.63e-05	0.000477	CbGpPWpGaD
Loperamide—CALM3—Myometrial Relaxation and Contraction Pathways—IL6—malaria	2.62e-05	0.000475	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling of activated FGFR—IL6—malaria	2.62e-05	0.000474	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling of activated FGFR—IL6—malaria	2.62e-05	0.000474	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD36—malaria	2.58e-05	0.000468	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD36—malaria	2.58e-05	0.000468	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—HBB—malaria	2.56e-05	0.000464	CbGpPWpGaD
Loperamide—CALM3—Downstream signal transduction—IL6—malaria	2.54e-05	0.000461	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—NOS2—malaria	2.54e-05	0.00046	CbGpPWpGaD
Loperamide—CALM2—Myometrial Relaxation and Contraction Pathways—IL6—malaria	2.53e-05	0.000459	CbGpPWpGaD
Loperamide—CALM1—Myometrial Relaxation and Contraction Pathways—IL6—malaria	2.53e-05	0.000459	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR—IL6—malaria	2.53e-05	0.000458	CbGpPWpGaD
Loperamide—CALM3—Signaling by ERBB2—IL6—malaria	2.52e-05	0.000456	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CRP—malaria	2.51e-05	0.000454	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—IL6—malaria	2.5e-05	0.000454	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—G6PD—malaria	2.48e-05	0.000449	CbGpPWpGaD
Loperamide—CALM1—Downstream signal transduction—IL6—malaria	2.46e-05	0.000446	CbGpPWpGaD
Loperamide—CALM2—Downstream signal transduction—IL6—malaria	2.46e-05	0.000446	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—NOS2—malaria	2.46e-05	0.000445	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—NOS2—malaria	2.46e-05	0.000445	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR—IL6—malaria	2.45e-05	0.000443	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR—IL6—malaria	2.45e-05	0.000443	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	2.45e-05	0.000443	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—IL6—malaria	2.43e-05	0.000441	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—IL6—malaria	2.43e-05	0.000441	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CRP—malaria	2.42e-05	0.000439	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CRP—malaria	2.42e-05	0.000439	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—IL6—malaria	2.42e-05	0.000439	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—IL6—malaria	2.42e-05	0.000439	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PKLR—malaria	2.42e-05	0.000439	CbGpPWpGaD
Loperamide—CALM3—Disease—DHFR—malaria	2.41e-05	0.000436	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—TLR4—malaria	2.4e-05	0.000435	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—IL2—malaria	2.38e-05	0.000432	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—IL6—malaria	2.36e-05	0.000427	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—IL6—malaria	2.36e-05	0.000427	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—malaria	2.36e-05	0.000427	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—IL6—malaria	2.33e-05	0.000423	CbGpPWpGaD
Loperamide—CALM2—Disease—DHFR—malaria	2.33e-05	0.000422	CbGpPWpGaD
Loperamide—CALM1—Disease—DHFR—malaria	2.33e-05	0.000422	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—TLR4—malaria	2.32e-05	0.000421	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—TLR4—malaria	2.32e-05	0.000421	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—DHODH—malaria	2.32e-05	0.00042	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—IL6—malaria	2.31e-05	0.000419	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—IL6—malaria	2.3e-05	0.000418	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PKLR—malaria	2.28e-05	0.000414	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—IL6—malaria	2.28e-05	0.000413	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—IL6—malaria	2.28e-05	0.000413	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—malaria	2.28e-05	0.000413	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—malaria	2.28e-05	0.000413	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—IL6—malaria	2.28e-05	0.000413	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—IL6—malaria	2.28e-05	0.000413	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TLR9—malaria	2.27e-05	0.000412	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—IL6—malaria	2.26e-05	0.000409	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—IL6—malaria	2.26e-05	0.000409	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—IL6—malaria	2.24e-05	0.000406	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—IL6—malaria	2.24e-05	0.000406	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—HPGDS—malaria	2.23e-05	0.000405	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—IL6—malaria	2.23e-05	0.000404	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—IL6—malaria	2.23e-05	0.000404	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ICAM1—malaria	2.21e-05	0.000401	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TLR9—malaria	2.2e-05	0.000398	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TLR9—malaria	2.2e-05	0.000398	CbGpPWpGaD
Loperamide—CALM3—Metabolism—HPGDS—malaria	2.17e-05	0.000394	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL2—malaria	2.16e-05	0.000392	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—G6PD—malaria	2.16e-05	0.000391	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ICAM1—malaria	2.14e-05	0.000388	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ICAM1—malaria	2.14e-05	0.000388	CbGpPWpGaD
Loperamide—CALM2—Metabolism—HPGDS—malaria	2.1e-05	0.000381	CbGpPWpGaD
Loperamide—CALM1—Metabolism—HPGDS—malaria	2.1e-05	0.000381	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—IL2—malaria	2.09e-05	0.000379	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.09e-05	0.000378	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.08e-05	0.000377	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—DHFR—malaria	2.07e-05	0.000375	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—SCARB1—malaria	2.05e-05	0.000371	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—G6PD—malaria	2.03e-05	0.000369	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.02e-05	0.000366	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.02e-05	0.000366	CbGpPWpGaD
Loperamide—CALM3—Metabolism—DHFR—malaria	2.02e-05	0.000365	CbGpPWpGaD
Loperamide—CALM3—Metabolism—SCARB1—malaria	1.99e-05	0.000362	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—KDR—malaria	1.97e-05	0.000357	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC4A1—malaria	1.97e-05	0.000357	CbGpPWpGaD
Loperamide—CALM2—Metabolism—DHFR—malaria	1.95e-05	0.000353	CbGpPWpGaD
Loperamide—CALM1—Metabolism—DHFR—malaria	1.95e-05	0.000353	CbGpPWpGaD
Loperamide—CALM2—Metabolism—SCARB1—malaria	1.93e-05	0.00035	CbGpPWpGaD
Loperamide—CALM1—Metabolism—SCARB1—malaria	1.93e-05	0.00035	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL2—malaria	1.9e-05	0.000344	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—IL6—malaria	1.89e-05	0.000343	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—HPGDS—malaria	1.89e-05	0.000343	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—DECR1—malaria	1.85e-05	0.000336	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—IL2—malaria	1.77e-05	0.00032	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—DHFR—malaria	1.75e-05	0.000318	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL18—malaria	1.74e-05	0.000316	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD40LG—malaria	1.74e-05	0.000315	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—SCARB1—malaria	1.74e-05	0.000314	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—IL2—malaria	1.73e-05	0.000314	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—KDR—malaria	1.73e-05	0.000313	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD8A—malaria	1.72e-05	0.000311	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CD4—malaria	1.69e-05	0.000307	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL18—malaria	1.69e-05	0.000305	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL18—malaria	1.69e-05	0.000305	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD40LG—malaria	1.68e-05	0.000304	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD40LG—malaria	1.68e-05	0.000304	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HBB—malaria	1.67e-05	0.000303	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—IL2—malaria	1.67e-05	0.000303	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—IL2—malaria	1.67e-05	0.000303	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD8A—malaria	1.66e-05	0.000301	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD8A—malaria	1.66e-05	0.000301	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-B—malaria	1.65e-05	0.000299	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—HPGDS—malaria	1.65e-05	0.000298	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CD4—malaria	1.64e-05	0.000297	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CD4—malaria	1.64e-05	0.000297	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD4—malaria	1.63e-05	0.000295	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD36—malaria	1.62e-05	0.000293	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—IL6—malaria	1.6e-05	0.000291	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL2—malaria	1.6e-05	0.000291	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-B—malaria	1.6e-05	0.000289	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-B—malaria	1.6e-05	0.000289	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD4—malaria	1.57e-05	0.000285	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD4—malaria	1.57e-05	0.000285	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD36—malaria	1.57e-05	0.000284	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD36—malaria	1.57e-05	0.000284	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—IL6—malaria	1.55e-05	0.000281	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—IL6—malaria	1.55e-05	0.000281	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—HPGDS—malaria	1.55e-05	0.000281	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—DHFR—malaria	1.53e-05	0.000277	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SCARB1—malaria	1.51e-05	0.000274	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PKLR—malaria	1.49e-05	0.00027	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—KDR—malaria	1.46e-05	0.000265	CbGpPWpGaD
Loperamide—CALM3—Immune System—CRP—malaria	1.46e-05	0.000265	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—DHFR—malaria	1.44e-05	0.000261	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SCARB1—malaria	1.42e-05	0.000258	CbGpPWpGaD
Loperamide—CALM2—Immune System—CRP—malaria	1.41e-05	0.000256	CbGpPWpGaD
Loperamide—CALM1—Immune System—CRP—malaria	1.41e-05	0.000256	CbGpPWpGaD
Loperamide—CALM3—Immune System—TLR4—malaria	1.4e-05	0.000254	CbGpPWpGaD
Loperamide—CALM2—Immune System—TLR4—malaria	1.35e-05	0.000245	CbGpPWpGaD
Loperamide—CALM1—Immune System—TLR4—malaria	1.35e-05	0.000245	CbGpPWpGaD
Loperamide—CALM3—Immune System—ICAM1—malaria	1.34e-05	0.000243	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—G6PD—malaria	1.33e-05	0.000241	CbGpPWpGaD
Loperamide—CALM2—Immune System—ICAM1—malaria	1.3e-05	0.000235	CbGpPWpGaD
Loperamide—CALM1—Immune System—ICAM1—malaria	1.3e-05	0.000235	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CD36—malaria	1.29e-05	0.000233	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL2—malaria	1.28e-05	0.000232	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL6—malaria	1.27e-05	0.000231	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CD36—malaria	1.25e-05	0.000227	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS2—malaria	1.23e-05	0.000223	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CD36—malaria	1.21e-05	0.000219	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CD36—malaria	1.21e-05	0.000219	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS2—malaria	1.19e-05	0.000215	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS2—malaria	1.19e-05	0.000215	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL2—malaria	1.12e-05	0.000203	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—malaria	1.12e-05	0.000202	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CD36—malaria	1.09e-05	0.000197	CbGpPWpGaD
Loperamide—CALM3—Immune System—IFNG—malaria	1.02e-05	0.000185	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HPGDS—malaria	1.01e-05	0.000184	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL2—malaria	9.93e-06	0.00018	CbGpPWpGaD
Loperamide—CALM2—Immune System—IFNG—malaria	9.87e-06	0.000179	CbGpPWpGaD
Loperamide—CALM1—Immune System—IFNG—malaria	9.87e-06	0.000179	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD4—malaria	9.86e-06	0.000179	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL2—malaria	9.6e-06	0.000174	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL2—malaria	9.6e-06	0.000174	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD4—malaria	9.54e-06	0.000173	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD4—malaria	9.54e-06	0.000173	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CD36—malaria	9.49e-06	0.000172	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL2—malaria	9.47e-06	0.000172	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—malaria	9.43e-06	0.000171	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—DHFR—malaria	9.41e-06	0.000171	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SCARB1—malaria	9.31e-06	0.000169	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—malaria	9.15e-06	0.000166	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—malaria	9.11e-06	0.000165	CbGpPWpGaD
Loperamide—CALM3—Disease—CD4—malaria	9.1e-06	0.000165	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL2—malaria	9.07e-06	0.000164	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KDR—malaria	9.05e-06	0.000164	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CD36—malaria	8.94e-06	0.000162	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—malaria	8.86e-06	0.00016	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—malaria	8.86e-06	0.00016	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—malaria	8.81e-06	0.00016	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—malaria	8.81e-06	0.00016	CbGpPWpGaD
Loperamide—CALM2—Disease—CD4—malaria	8.81e-06	0.00016	CbGpPWpGaD
Loperamide—CALM1—Disease—CD4—malaria	8.81e-06	0.00016	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL2—malaria	8.77e-06	0.000159	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL2—malaria	8.77e-06	0.000159	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KDR—malaria	8.75e-06	0.000159	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KDR—malaria	8.75e-06	0.000159	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—malaria	7.51e-06	0.000136	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—malaria	6.59e-06	0.000119	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2—malaria	5.86e-06	0.000106	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CD36—malaria	5.85e-06	0.000106	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—malaria	5.84e-06	0.000106	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2—malaria	5.67e-06	0.000103	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2—malaria	5.67e-06	0.000103	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—malaria	5.64e-06	0.000102	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—malaria	5.64e-06	0.000102	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—malaria	5.57e-06	0.000101	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—malaria	5.33e-06	9.66e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—malaria	5.16e-06	9.35e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—malaria	5.16e-06	9.35e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—malaria	4.92e-06	8.92e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—malaria	4.76e-06	8.63e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—malaria	4.76e-06	8.63e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—malaria	3.45e-06	6.25e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—malaria	3.33e-06	6.04e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—malaria	3.33e-06	6.04e-05	CbGpPWpGaD
